CAMELLIX, LLC

Medtech

Alcohol-based hand hygiene formulation containing epigallocatechin-3-gallate-palmitate (EC16) for sporicidal activity

Grants
$2.2M
5 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Novel sanitizer against viral infections with long-lasting effect$192,601
Federal grantDepartment of Health and Human Services · Phase II · Novel sanitizer/disinfectants against viral infections with long-lasting effect$705,771
Federal grantDepartment of Health and Human Services · Phase II · Novel sanitizer/disinfectants against viral infections with long-lasting effect$653,249
Federal grantDepartment of Health and Human Services · Phase I · Novel Nasal Formulations Containing EC16 for Minimizing COVID-19-Associated Anosmia$384,971
Federal grantDepartment of Health and Human Services · Phase I · Feasibility study of novel hand hygiene formulations against bacterial spore infection$266,592
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1525ELITE ATHLETE PRODUCTS INC——
1526CURI BIO, INC.——
1527Caeli Vascular LLC——
1528CAMELLIX, LLC——
1529Apex Cool Labs, Inc.—$65K
1530FLUIDION US Inc——
1531Mitovation, Inc.—$500K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.